Rhine Biogenics Private Limited, a active private limited company, was established on 08 October 2003 in Palghat, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232KL2003PTC016519. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.97 Cr.
It upholds a compliant status. Employing 47 professional, Its leadership includes Ajith Sukumaran Nair (Director), Reji Joy (Director), Ajitkumar Warrior (Director). Past directors included Pallipuram Ranganathan Sreeram. It holds ₹1.37 Cr open charges and ₹2.79 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21/555 (3) Adithya Nagar, East Vennakkara Nurani Post Office, Palghat, Kerala, 678004.
U24232KL2003PTC016519
016519
08 October 2003
₹5.00 Cr
₹2.97 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Rhine Biogenics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajith Sukumaran Nair | Director | 17 Nov 2003 | Current |
| Reji Joy | Director | 17 Nov 2003 | Current |
| Ajitkumar Warrior | Director | 08 Oct 2003 | Current |
| Jayakumar Narayanan Nair | Director | 17 Nov 2003 | Current |
| Peter Jose Ansal Parriathcherry | Director | 17 Nov 2003 | Current |
| Kallungal Unni Jothish | Director | 17 Nov 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Dec 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rhine Biogenics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.63% increase. The company also saw a slight decrease in profitability, with a 6.82% decrease in profit. The company's net worth Soared by an impressive increase of 24.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rhine Biogenics had a promoter holding of 14.85% and a public holding of 85.15%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,724,276.00
₹27,897,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2022 | Others | ₹2.60 M | Open |
| 14 Jul 2022 | Others | ₹1.00 M | Open |
| 04 Mar 2022 | Hdfc Bank Limited | ₹4.20 M | Open |
| 31 Dec 2021 | Hdfc Bank Limited | ₹4.20 M | Open |
| 06 Nov 2019 | Axis Bank Limited | ₹1.72 M | Open |
Explore comprehensive loan charge details -
Rhine Biogenics has a workforce of 47 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rhine Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhine Biogenics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rhine Biogenics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Rhine Biogenics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
A charge with Others amounted to Rs. 0.26 Cr with Charge ID 100612688 was registered on 01 Sep 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100599136 was registered on 14 Jul 2022. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.42 Cr with Charge ID 100548792 was registered on 04 Mar 2022. was documented.
The activity A charge registered on 31 Jan 2017 via Charge ID 100095738 with Others was fully satisfied on 14 Feb 2022. was completed.
The CIN of Rhine Biogenics Private Limited is U24232KL2003PTC016519.
Rhine Biogenics Private Limited is headquartered at 21/555 (3) Adithya Nagar, East Vennakkara Nurani Post Office, Palghat, Kerala, 678004.
Rhine Biogenics Private Limited was incorporated on 08 October 2003.
The current directors of Rhine Biogenics Private Limited are
The primary industry of Rhine Biogenics Private Limited is Trade.
Rhine Biogenics Private Limited is unlisted.
The authorized capital of Rhine Biogenics Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.97 Cr.
The compliance status of Rhine Biogenics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX